The Longer-term Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia

被引：0
|
作者：
Raal, Frederick J.
Rosenson, Robert S.
Reeskamp, Laurens F.
Hovingh, G. Kees
Kastelein, John J.
Rubba, Paolo
Ali, Shazia
Banerjee, Poulabi
Chan, Kuo-Chen
Khilla, Nagwa
Pordy, Robert
Zhang, Yi
Gaudet, Daniel
机构：
来源：
CIRCULATION | 2020年 / 142卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A14407
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety of Ongericimab in Chinese Patients With Homozygous Familial Hypercholesterolemia
    Lin, Jie
    Chen, Jiyan
    Zhang, Ruiyan
    Wang, Jingfeng
    Bai, Xuelian
    Yan, Hui
    Yu, Jianjun
    Yao, Sheng
    Feng, Hui
    Lin, Jie
    CIRCULATION, 2022, 146
  • [22] Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia
    Harada-Shiba, Mariko
    Ikewaki, Katsunori
    Nohara, Atsushi
    Otsubo, Yoshihiko
    Yanagi, Koji
    Yoshida, Masayuki
    Chang, Qing
    Foulds, Pamela
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2017, 24 (04) : 402 - 411
  • [23] Evinacumab: a new option in the treatment of homozygous familial hypercholesterolemia
    Pirillo, Angela
    Catapano, Alberico L.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (07) : 813 - 820
  • [24] Will evinacumab become the standard treatment for homozygous familial hypercholesterolemia?
    Doggrell, Sheila A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (03) : 299 - 302
  • [25] Complementary role of evinacumab in combination with lipoprotein apheresis in patients with homozygous familial hypercholesterolemia
    Duell, Paul Barton
    Warden, Bruce A. A.
    THERAPEUTIC APHERESIS AND DIALYSIS, 2022, 26 : 12 - 17
  • [26] Evinacumab as an adjunct to lipid apheresis in an infant with homozygous familial hypercholesterolemia
    Stirnkorb, Christian
    Ney, Verena
    Bergmann, Carsten
    Bald, Martin
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2025,
  • [27] LONG-TERM EFFICACY OF EVINACUMAB AND IMPROVED CARDIOVASCULAR OUTCOME IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA
    Beliard, Sophie
    Saheb, Samir
    Litzler-Renault, Stephanie
    Vimont, Alexandre
    Valero, Rene
    Bruckert, Eric
    Farnier, Michel
    Gallo, Antonio
    ATHEROSCLEROSIS, 2024, 395
  • [28] Evinacumab for children with homozygous familial hypercholesterolemia: a plain language summary
    Wiegman, Albert
    Pordy, Robert
    FUTURE CARDIOLOGY, 2025, 21 (03) : 139 - 147
  • [29] A mini-review of efficacy, safety, and influence of novel evinacumab on familial hypercholesterolemia
    Olatunji, Gbolahan
    Kokori, Emmanuel
    Moradeyo, Abdulrahmon Akanmu
    Lema, Kaleb
    Ayo, Olanipekun Ridwan
    Obasanjo, Opabode Muntaqim
    Mustapha, Mubarak Jolayemi
    Stanley, Anthony Chidera
    Aderinto, Nicholas
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2024, 36 (01):
  • [30] Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia
    Gagné, C
    Gaudet, D
    Bruckert, E
    CIRCULATION, 2002, 105 (21) : 2469 - 2475
12345